These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18259006)

  • 1. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
    Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
    Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice.
    Gürgen D; Hegner B; Kusch A; Catar R; Chaykovska L; Hoff U; Gross V; Slowinski T; da Costa Goncalves AC; Kintscher U; Gustafsson JÅ; Luft FC; Dragun D
    Hypertension; 2011 Mar; 57(3):648-54. PubMed ID: 21300662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model.
    Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D
    Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium restores vasorelaxation of resistance arterioles in non-hypertensive DOCA/salt fed mice.
    Wyss C; Wang Q; Golshayan D; Nussberger J; Burnier M; Lehr HA; Schaefer SC
    Microvasc Res; 2012 Nov; 84(3):340-4. PubMed ID: 23009953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
    Wang Q; Domenighetti AA; Schäfer SC; Weber J; Simon A; Maillard MP; Pedrazzini T; Chen J; Lehr HA; Burnier M
    Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(9):R1025-33. PubMed ID: 22403797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
    Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vascular function and morphology in hydralazine treated DOCA salt rats.
    Anderson PG; Bishop SP; Digerness SB
    J Mol Cell Cardiol; 1988 Oct; 20(10):955-67. PubMed ID: 2975341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
    Loch D; Hoey A; Brown L
    Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
    Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
    Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.
    Solocinski K; Holzworth M; Wen X; Cheng KY; Lynch IJ; Cain BD; Wingo CS; Gumz ML
    Acta Physiol (Oxf); 2017 May; 220(1):72-82. PubMed ID: 27636900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic arsenic induces sex-dependent pathological hypertrophy in the heart.
    Kabir R; Sinha P; Mishra S; Ebenebe OV; Taube N; Oeing CU; Keceli G; Chen R; Paolocci N; Rule A; Kohr MJ
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1321-H1336. PubMed ID: 33481702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
    Tiritilli A; Ruff F
    Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
    Machnik A; Dahlmann A; Kopp C; Goss J; Wagner H; van Rooijen N; Eckardt KU; Müller DN; Park JK; Luft FC; Kerjaschki D; Titze J
    Hypertension; 2010 Mar; 55(3):755-61. PubMed ID: 20142563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.
    de Almeida PW; Melo MB; Lima Rde F; Gavioli M; Santiago NM; Greco L; Jesus IC; Nocchi E; Parreira A; Alves MN; Mitraud L; Resende RR; Campagnole-Santos MJ; Dos Santos RA; Guatimosim S
    Hypertension; 2015 Aug; 66(2):389-95. PubMed ID: 26077567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF; Rossoni LV
    J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
    Obst M; Gross V; Luft FC
    J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.